1-9 of 9
Igor Espinoza-Delgado, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma

Beata Holkova, MD, Edward B. Perkins, MD, PhD, Lubomir Sokol, MD, PhD, Kristy L. Richards, PhD, MD, Samir Parekh, MD, Rebecca Elstrom, MD, Ashraf Z. Badros, MD, Igor Espinoza-Delgado, MD, Michael J. Schell, PhD, Amy Kimball, MD, PhD, Mary Beth Tombes, RN, Ellen Shrader, Heidi Sankala, PhD, Domenico Coppola, MD, Maciej Kmieciak, PhD, Daniel Sullivan, MD, John D. Roberts, MD, Steven Grant, MD
Journal: Blood
Blood (2011) 118 (21): 779.
https://doi.org/10.1182/blood.V118.21.779.779
Published: 2011
Journal Articles

Final Results From a Phase II Trial of Triapine® Plus Fludarabine for Adults with Aggressive Myeloproliferative Disorders

Michael A McDevitt, MD, PhD, Robert L Dilley, Keith W. Pratz, MD, B. Douglas Smith, MD, Alison R. Moliterno, MD, Yun Yen, MD, PhD, Lisa Malick, RN, Steven D. Gore, MD, Richard J. Jones, Jaroslaw P. Maciejewski, MD, PhD, Igor Espinoza-Delgado, MD, Judith E. Karp, MD
Journal: Blood
Blood (2011) 118 (21): 1755.
https://doi.org/10.1182/blood.V118.21.1755.1755
Published: 2011
Journal Articles

Combinations of the Histone Deacetylase Inhibitor Entinostat (SNDX-275, MS-275) and Imatinib Have Divergent Effects in Imatinib-Sensitive Vs. Imatinib-Resistant p210- BCR/ABL Expressing Cell Lines.

Rachel E. Rau, MD, Emily McIntyre, Scott H. Kaufmann, MD, PhD, Igor Espinoza-Delgado, MD, Judith Karp, Patrick Brown, MD
Journal: Blood
Blood (2009) 114 (22): 2742.
https://doi.org/10.1182/blood.V114.22.2742.2742
Published: 2009
Journal Articles

Phase I Trial of Vorinostat (SAHA) in Combination with Alvocidib (Flavopiridol) in Patients with Relapsed, Refractory or (Selected) Poor Prognosis Acute Leukemia or Refractory Anemia with Excess Blasts-2 (RAEB-2)

Steven Grant, MD, Sarah Kolla, Leonardo Andres Sirulnik, MD, PhD, Geoffrey Shapiro, Jeffrey Supko, Brenda Cooper, Edward Perkins, Viswanathan Ramakrishnan, Igor Espinoza-Delgado, MD, M B Tombes, John D Roberts
Journal: Blood
Blood (2008) 112 (11): 2986.
https://doi.org/10.1182/blood.V112.11.2986.2986
Published: 2008
Journal Articles

A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma. A California Cancer Consortium Study.

Mark Kirschbaum, MD, Leslie Popplewell, Auayporn P. Nademanee, Vinod Pullarkat, Maria Delioukina, Jasmine M. Zain, Deron Matsuoka, Bernadette Pulone, Paul Frankel, Igor Espinoza-Delgado, MD, Stephen J. Forman, David Gandara, Edward Newman
Journal: Blood
Blood (2008) 112 (11): 1564.
https://doi.org/10.1182/blood.V112.11.1564.1564
Published: 2008
Journal Articles

A Phase I Trial of the Epigenetic Modulators Vorinostat, in Combination with Azacitidine (azaC) in Patients with the Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML): A Study of the New York Cancer Consortium

Lewis R. Silverman, MD, Amit Verma, Rosalie Odchimar-Reissig, Amanda LeBlanc, Vesna Najfeld, Janice Gabrilove, Luis Isola, Igor Espinoza-Delgado, MD, James Zwiebel
Journal: Blood
Blood (2008) 112 (11): 3656.
https://doi.org/10.1182/blood.V112.11.3656.3656
Published: 2008
Journal Articles

Phase I Trial of Vorinostat Combined with Cytarabine and Etoposide in Patients (pts) with Advanced Acute Leukemia and High-Risk Myelodysplastic Syndromes

Ivana Gojo, MD, Ming T. Tan, PhD, Ken Shiozawa, MD, PhD, Takeo Nakanishi, PhD, Angelika M Burger, PhD, Colette L Burgess, BS, Merrill J Egorin, MD, Maria R. Baer, MD, Michael L Tidwell, RN, CRNP, Rakesh Srivastava, PhD, France Carrier, PhD, Angela Scardina, RN, Igor Espinoza-Delgado, MD, Douglas D. Ross, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4011.
https://doi.org/10.1182/blood.V112.11.4011.4011
Published: 2008
Journal Articles

High Response Rates in Acute Steroid Refractory Graft-Versus-Host Disease (GVHD) Following Combined Tumor Necrosis Factor-alpha (TNF-α) and Interleukin-2 (IL-2) Blockade.

Ramaprasad Srinivasan, MD, PhD, Nancy Geller, PhD, Colleen Dorrance, MD, Igor Espinoza-Delgado, MD, A. John Barrett, MD, Yoshiyuki Takahashi, MD, PhD, Richard W. Childs, MD
Journal: Blood
Blood (2005) 106 (11): 1801.
https://doi.org/10.1182/blood.V106.11.1801.1801
Published: 2005
Journal Articles

Evaluation of Three Different Cyclosporine-Based Graft Versus Host Disease (GVHD) Prophylaxis Regimens Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

Ramaprasad Srinivasan, MD, PhD, Nancy Geller, PhD, Sakti Chakrabarti, MD, Igor Espinoza-Delgado, MD, Teresa Donohue, Susan Leitman, MD, Charles D. Bolan, MD, Elizabeth J. Read, MD, John A. Barrett, MD, Richard W. Childs, MD
Journal: Blood
Blood (2004) 104 (11): 1236.
https://doi.org/10.1182/blood.V104.11.1236.1236
Published: 2004